Individuals who carry the breast cancer genes BRCA1 or BRCA2 are often unaware of the fact. That suggests that physicians need a new way to apply DNA-based screens to identify those at risk.
- Professor of Genetics and Director for Clinical Operations in the Center for Genomic Health, Yale University
Contact Michael for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: New Haven, Connecticut, U.S.
- Website
- Article Feed
- Joined
